Eiko Ozono

Eiko Ozono is a highly experienced postdoctoral researcher with a strong background in cancer biology and molecular mechanisms. Currently serving as a Postdoctoral Project Research Scientist at The Francis Crick Institute since November 2016, Eiko has led a project focused on G1 arrest and Cyclin E overexpression, with findings presented at a major conference and a manuscript in preparation. Previous roles include a Postdoctoral Training Fellow at The Francis Crick Institute, where Eiko conducted a genome-wide siRNA screen to identify DNA damage enhancers, and a Postdoctoral Research Scientist at The Babraham Institute, contributing to research on MEK inhibitor resistance, resulting in co-authoring two peer-reviewed publications. Eiko's foundational research experience includes positions at Barts Cancer Institute and Tokyo Medical and Dental University, and a solid educational background featuring a PhD, MSc, and BS in relevant scientific disciplines. Research expertise encompasses mammalian cell culture, Western blotting, and various molecular biology techniques.